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Blood groups, finger prints, iris scans and DNA bar codes
are several ways to distinguish or identify individual
humans. According to Arumugam and colleagues (2011)
we can now also be distinguished by the microbial com-
munities in our faeces, our ‘enterotypes’.
The human gut is one of the most densely populated
ecosystems known, and although this ecosystem con-
tains members of the three domains of life – bacteria,
archaea and eucarya (Finegold et al., 1983) – it is domi-
nated by bacteria. They are essential in digesting the food
we eat and in keeping us healthy by stimulating our
immune system and fighting off pathogenic bacteria. It is
estimated that 1013–1014 microbes inhabit our gastrointes-
tinal tract (GIT), with the greatest number residing in the
distal gut, where they synthesize essential vitamins and
process otherwise indigestible components of our diet
such as plant polysaccharides (Backhed et al., 2005).
Early studies used 16S ribosomal DNA (rDNA) analysis to
type and enumerate the distal gut and faecal microbiota.
More than 90% of the bacterial phylotypes present in the
intestinal microbiota in healthy humans are members of
only three bacterial divisions: the Bacteroidetes, the Fir-
micutes and the Actinobacteria (Zoetendal et al., 2006).
Nevertheless, each healthy adult’s gut appears to have
a unique and relatively stable microbiota (Zoetendal et al.,
1998; Turnbaugh et al., 2007), which is a reflection of the
numerous different phylogenetic clusters among the Firmi-
cutes, Clostridium clusters IV, IX and XIVa, including the
predominant genera Clostridium, Eubacterium, Roseburia
and Ruminococcus. Furthermore, the Actinobacteria that
encompass mainly the genera Bifidobacterium and Atopo-
bium also represent important members of the gut micro-
bial community (Harmsen et al., 2002; Turroni et al., 2008).
Notably, recent estimates of the diversity of the human gut
microbial ecosystem indicate it may encompass more than
1000 species and a multitude of strains (Backhed et al.,
2005; Blaut and Clavel, 2007; Rajilic-Stojanovic et al.,
2007). Microbiota composition studies in humans have
discovered that aberrations in the microbiome composition
is present in obese individuals (Ley et al., 2006; Turnbaugh
et al., 2009) as well as in individuals with a variety of other
diseases (Zoetendal et al., 2008).
Since the largest part (~80%) of gut microbes remains
uncultured, metagenomics analysis has become fashion-
able in the past 5 years to estimate the types, relative
abundance and genome content of microbes in various
parts of the GIT. The first metagenomics analysis from just
two faecal samples (Gill et al., 2006) led to early insight
into enrichment of genes encoding specific metabolic
pathways, including metabolism associated with glycans,
amino acids and xenobiotics, but also methanogenesis
and biosynthesis of vitamins and isoprenoids. However,
this early study provided only a very fragmented view due
to limitations in sample size, sequencing technology,
number of bases sequenced and availability of suitable
reference genomes of gut inhabitants.
Gut microbial reference genomes
Large efforts have now been initiated to make catalogues
of reference genomes from the human gut microbiome.
Research groups from around the world have launched
an International Human Microbiome Consortium (IHMC)
which together aims to sequence more than 1000 human
bacterial reference genomes, including 900 genomes
from many body sites (but mainly the GIT) by the Human
Microbiome Jumpstart Reference Strains Consortium
(Nelson et al., 2010) (http://www.hmpdacc.org/project_
catalog.html) and 100 gut genomes by the MetaHIT Con-
sortium (http://www.sanger.ac.uk/resources/downloads/
bacteria/metahit/). The MetaHIT sequencing project,
coordinated by the Sanger Institute in the UK and funded
by the European Commission, aims to sequence 30
strains of cultured gut bacteria, and 70 individual isolated
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cells of uncultured gut bacteria by single-cell genome
sequencing (de Jager and Siezen, 2011).
Human gut microbial gene catalogues
Later metagenomics studies generated some 3 Gb of
microbial sequence from faecal samples of 33 individuals
from the USA and Japan (Kurokawa et al., 2007; Turn-
baugh and Gordon, 2009; Turnbaugh et al., 2009). More
recently, Illumina sequencing of DNA from faecal samples
from 144 European adults generated 577 Gb of DNA
sequence, almost 200 times more sequence than all pre-
vious studies (Qin et al., 2010). After assembly, a non-
redundant set of 3.3 million gut ORFs was obtained which
mapped well to 89 reference gut genomes. The cohort
harboured a total of 1000–1150 prevalent bacterial
species, and each individual had at least 160 of these
species. This large data set allowed an in-depth assess-
ment of the bacterial functions important for life in the gut,
and gut-specific functions for adhesion to the host epithe-
lial proteins and for harvesting sugars of the globoseries
glycolipids (Qin et al., 2010).
Enterotypes
Now, in a May 2011 issue of Nature, gut metagenomics
data sets from 39 samples from six nationalities, including
newly sequenced 22 European faecal samples, have
been combined and the DNA sequence reads compared
with 1511 reference genomes including 389 publicly avail-
able human microbiome genomes generated through the
IHMC and MetaHIT consortia (Arumugam et al., 2011).
Nearly 53% of the sequence reads could be robustly
assigned to a genus in the reference genome set, and
80% could be assigned to a phylum. The phylogenetic
composition confirmed that the Firmicutes and Bacterio-
detes phyla are the most dominant in the human faecal
samples. Multidimensional cluster analysis and principal
component analysis (PCA) revealed that the gut samples
separate into three robust clusters, designated as ‘entero-
types’. Each of the three enterotypes is identifiable by
Fig. 1. Phylogenetic differences between enterotypes. Between-class analysis, which visualizes results from PCA and clustering, of the genus
compositions of 33 Sanger metagenomes estimated by mapping the metagenome reads to 1511 reference genome sequences using an 85%
similarity threshold (a), Danish subset containing 85 metagenomes from a published Illumina data set (b), and 154 pyrosequencing-based
16S sequences (c) reveals three robust clusters that we call enterotypes. Two principal components are plotted using the ade4 package in R
with each sample represented by a filled circle. The centre of gravity for each cluster is marked by a rectangle and the coloured ellipse covers
67% of the samples belonging to the cluster. IBD, inflammatory bowel disease. Adapted by permission from Macmillan Publishers: Nature
(Arumugam et al., 2011), copyright 2011.
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variation in the levels of one of three main genera: Bac-
teriodetes (enterotype 1), Prevotella (enterotype 2) and
Ruminococcus (enterotype 3) (Fig. 1a). The same analy-
sis performed on two larger published human microbiome
data sets generated the same three enterotype clusters
(Fig. 1b and c).
Phylogenetic and functional differences among entero-
types seem to reflect different combinations of microbial
trophic chains. The abundances and co-occurrence net-
works of the three enterotypes from the Sanger metage-
nomes are shown in Fig. 2. The drivers of enterotype 1
(mainly Bacteriodetes, co-occurring with, e.g. Parabac-
teriodetes) appear to derive energy mainly from fermen-
tation of carbohydrates as these genera have a very
broad saccharolytic potential. In enterotype 2, the Pre-
votella and co-occurring Desulfovibrio can act in synergy
to degrade mucin glycoproteins of the gut mucosal layer,
while in enterotype 3 the Ruminococcus and Akkerman-
sia can bind mucins and transport and degrade the con-
stituent sugars. Enterotypes 1 and 2 are also enriched in
biosynthesis of different vitamins (Arumugam et al.,
2011). Surprisingly, the enterotypes do not correlate with
host properties such as nationality, age, gender or body
mass index. However, data-driven marker genes or func-
tional modules were identified for most of these host
properties.
Future perspectives
This study indicates the existence of a limited number of
well-balanced host–microbial symbiotic states in human
faeces that presumably reflect the microbial composition
in the large intestine. Perhaps it would have been wiser to
call these ‘faecotypes’ than ‘enterotypes’, since it is well
known that the microbial abundance and composition
changes dramatically throughout the GIT. It remains to be
seen whether such stable and universal microbial consor-
tia are also found in the small intestine where the genera
Streptococcus, Clostridium and Veillonella are dominant
(Booijink et al., 2007; 2010a,b; van den Bogert et al.,
2011).
This is an exciting field of research, where much is still
to be learned about how stable enterotypes are formed
and maintained in humans and other animals, and
whether they can be influenced by diets, probiotics, drugs
or diseases (Kau et al., 2011; Walter and Ley, 2011).
Fig. 2. Main contributors to enterotypes.
a. Phylum abundance box plots of the main contributors of each enterotype from the Sanger metagenomes as determined by read
abundance.
b. Co-occurrence networks of the three enterotypes from the Sanger metagenomes. Unclassified genera under a higher rank are marked by
asterisks.
Adapted by permission from Macmillan Publishers: Nature (Arumugam et al., 2011), copyright 2011.
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